LEADER 02664nam 2200529Ia 450 001 9910816016903321 005 20230721015940.0 010 $a92-9021-714-6 035 $a(CKB)2670000000033938 035 $a(EBL)538063 035 $a(OCoLC)694342017 035 $a(SSID)ssj0000432091 035 $a(PQKBManifestationID)11269973 035 $a(PQKBTitleCode)TC0000432091 035 $a(PQKBWorkID)10477478 035 $a(PQKB)11560688 035 $a(MiAaPQ)EBC538063 035 $a(Au-PeEL)EBL538063 035 $a(CaPaEBR)ebr10392232 035 $a(EXLCZ)992670000000033938 100 $a20090311d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aMeasuring transparency to improve good governance in the public pharmaceutical sector$iLebanon$b[electronic resource] 210 $aCairo, Egypt $cWorld Health Organization, Regional Office for the Eastern Mediterranean$dc2009 215 $a1 online resource (79 p.) 300 $aDescription based upon print version of record. 311 $a92-9021-651-4 320 $aIncludes bibliographical references. 327 $aCOVER; TITLE; COPYRIGHT; Contents; Foreword; Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Lebanon; 3. Methodology; 4. Results and data presentations; 5. Data analysis and discussion; 6. Recommendations; 7. Conclusions; 8. Resource documents; Annexes 330 $aThis report presents the results of a transparency assessment carried out in Lebanon. It gives a comprehensive assessment of the level of transparency and the level of vulnerability to corruption within the six primary functions of the pharmaceutical sector - registration, inspection, promotion, selection, procurement and distribution of medicines. The methodology provides both qualitative and quantitative information. Three national investigators, selected by the Ministry of Health, collected data by conducting a series of interviews with 50 carefully selected key informants. The inform 606 $aPharmaceutical industry$xStandards$zLebanon 606 $aPharmaceutical policy$zLebanon 615 0$aPharmaceutical industry$xStandards 615 0$aPharmaceutical policy 676 $a331 712 02$aWorld Health Organization.$bRegional Office for the Eastern Mediterranean. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910816016903321 996 $aMeasuring transparency to improve good governance in the public pharmaceutical sector$93982904 997 $aUNINA